SCHEMBL845048

SCHEMBL845048

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccn3)cc2)cc1)[C@@H]1CCCN1C(=O)c1ccccn1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 4/20 0.50
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
PABPC1 P11940 1/20 0.45
ALDH1A1 P00352 3/20 0.45
HTT P42858 2/20 0.45
MAPK1 P28482 1/20 0.45
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
PKM P14618 1/20 0.44
RAB9A P51151 1/20 0.44
KLF5 Q13887 1/20 0.44
RHOC P08134 1/20 0.44
RHOA P61586 1/20 0.44
KDM4E B2RXH2 2/20 0.43
GAA P10253 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844963 0.93 DGAT1 (0.47) DGAT1CYP2C9CYP2C19PABPC1ALDH1A1
SCHEMBL845250 0.91 HCRTR1 (0.46) DGAT1CYP2C9CYP2C19PABPC1ALDH1A1
SCHEMBL845935 0.90 PABPC1 (0.44) DGAT1CYP2C9CYP2C19PABPC1ALDH1A1
SCHEMBL845643 0.89 MAPK1 (0.50) DGAT1CYP2C9CYP2C19PABPC1ALDH1A1
SCHEMBL845405 0.87 TRPV1 (0.46) DGAT1CYP2C9CYP2C19HTTMAPT
SCHEMBL13272265 0.86 DGAT1 (0.41) DGAT1CYP2C9CYP2C19PABPC1ALDH1A1
SCHEMBL13272381 0.84 PABPC1 (0.40) DGAT1CYP2C9CYP2C19PABPC1ALDH1A1
SCHEMBL4924225 0.84 L3MBTL1 (0.50) DGAT1
SCHEMBL4924222 0.84 L3MBTL1 (0.50) DGAT1
SCHEMBL845442 0.83 CYP2C9 (0.43) CYP2C9CYP2C19PABPC1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed